Cargando…

Role of pharmacist during the COVID-19 pandemic: A scoping review

BACKGROUND: Since the start of the new Coronavirus (COVID-19) outbreak in December 2019, pharmacists worldwide are playing a key role adopting innovative strategies to minimize the adverse impact of the pandemic. OBJECTIVES: To identify and describe core services provided by the pharmacist during th...

Descripción completa

Detalles Bibliográficos
Autores principales: Visacri, Marília Berlofa, Figueiredo, Isabel Vitória, Lima, Tácio de Mendonça
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334137/
https://www.ncbi.nlm.nih.gov/pubmed/33317760
http://dx.doi.org/10.1016/j.sapharm.2020.07.003
_version_ 1783553872241885184
author Visacri, Marília Berlofa
Figueiredo, Isabel Vitória
Lima, Tácio de Mendonça
author_facet Visacri, Marília Berlofa
Figueiredo, Isabel Vitória
Lima, Tácio de Mendonça
author_sort Visacri, Marília Berlofa
collection PubMed
description BACKGROUND: Since the start of the new Coronavirus (COVID-19) outbreak in December 2019, pharmacists worldwide are playing a key role adopting innovative strategies to minimize the adverse impact of the pandemic. OBJECTIVES: To identify and describe core services provided by the pharmacist during the COVID-19 pandemic. METHODS: A literature search was performed in MEDLINE, Embase, Scopus, and LILACS for studies published between December 1st, 2019 and May 20th, 2020 without language restriction. Studies that reported services provided by pharmacists during the COVID-19 pandemic were included. Two independent authors performed study selection and data extraction with a consensus process. The pharmacist's intervention identified in the included studies were described based on key domains in the DEPICT v.2. RESULTS: A total of 1189 records were identified, of which 11 studies fully met the eligibility criteria. Most of them were conducted in the United States of America (n = 4) and China (n = 4). The most common type of publication were letters (n = 4) describing the workplace of the pharmacist in hospitals (n = 8). These findings showed the different roles of pharmacists during the COVID-19 pandemic, such as disease prevention and infection control, adequate storage and drug supply, patient care and support for healthcare professionals. Pharmacists' interventions were mostly conducted for healthcare professionals and patients (n = 7), through one-to-one contact (n = 11), telephone (n = 6) or video conference (n = 5). The pharmacists' main responsibility was to provide drug information for healthcare professionals (n = 7) as well as patient counseling (n = 8). CONCLUSIONS: A reasonable number of studies that described the role of the pharmacists during the COVID-19 pandemic were found. All studies reported actions taken by pharmacists, although without providing a satisfactory description. Thus, future research with more detailed description as well as an evaluation of the impact of pharmacist intervention is needed in order to guide future actions in this and/or other pandemic.
format Online
Article
Text
id pubmed-7334137
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-73341372020-07-06 Role of pharmacist during the COVID-19 pandemic: A scoping review Visacri, Marília Berlofa Figueiredo, Isabel Vitória Lima, Tácio de Mendonça Res Social Adm Pharm Article BACKGROUND: Since the start of the new Coronavirus (COVID-19) outbreak in December 2019, pharmacists worldwide are playing a key role adopting innovative strategies to minimize the adverse impact of the pandemic. OBJECTIVES: To identify and describe core services provided by the pharmacist during the COVID-19 pandemic. METHODS: A literature search was performed in MEDLINE, Embase, Scopus, and LILACS for studies published between December 1st, 2019 and May 20th, 2020 without language restriction. Studies that reported services provided by pharmacists during the COVID-19 pandemic were included. Two independent authors performed study selection and data extraction with a consensus process. The pharmacist's intervention identified in the included studies were described based on key domains in the DEPICT v.2. RESULTS: A total of 1189 records were identified, of which 11 studies fully met the eligibility criteria. Most of them were conducted in the United States of America (n = 4) and China (n = 4). The most common type of publication were letters (n = 4) describing the workplace of the pharmacist in hospitals (n = 8). These findings showed the different roles of pharmacists during the COVID-19 pandemic, such as disease prevention and infection control, adequate storage and drug supply, patient care and support for healthcare professionals. Pharmacists' interventions were mostly conducted for healthcare professionals and patients (n = 7), through one-to-one contact (n = 11), telephone (n = 6) or video conference (n = 5). The pharmacists' main responsibility was to provide drug information for healthcare professionals (n = 7) as well as patient counseling (n = 8). CONCLUSIONS: A reasonable number of studies that described the role of the pharmacists during the COVID-19 pandemic were found. All studies reported actions taken by pharmacists, although without providing a satisfactory description. Thus, future research with more detailed description as well as an evaluation of the impact of pharmacist intervention is needed in order to guide future actions in this and/or other pandemic. Elsevier Inc. 2021-01 2020-07-04 /pmc/articles/PMC7334137/ /pubmed/33317760 http://dx.doi.org/10.1016/j.sapharm.2020.07.003 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Visacri, Marília Berlofa
Figueiredo, Isabel Vitória
Lima, Tácio de Mendonça
Role of pharmacist during the COVID-19 pandemic: A scoping review
title Role of pharmacist during the COVID-19 pandemic: A scoping review
title_full Role of pharmacist during the COVID-19 pandemic: A scoping review
title_fullStr Role of pharmacist during the COVID-19 pandemic: A scoping review
title_full_unstemmed Role of pharmacist during the COVID-19 pandemic: A scoping review
title_short Role of pharmacist during the COVID-19 pandemic: A scoping review
title_sort role of pharmacist during the covid-19 pandemic: a scoping review
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334137/
https://www.ncbi.nlm.nih.gov/pubmed/33317760
http://dx.doi.org/10.1016/j.sapharm.2020.07.003
work_keys_str_mv AT visacrimariliaberlofa roleofpharmacistduringthecovid19pandemicascopingreview
AT figueiredoisabelvitoria roleofpharmacistduringthecovid19pandemicascopingreview
AT limataciodemendonca roleofpharmacistduringthecovid19pandemicascopingreview